CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-17 | Plavsic Mark Chief Technology Officer | Sale | −15,890 | $5.05 | $80K | 181,397 |
| 2026-02-17 | Hopkins Janet Jill Chief Medical Officer | Sale | −20,401 | $5.06 | $103K | 232,284 |
| 2026-02-17 | Elazzouzi Amy Senior Vice President, Finance | Sale | −8,549 | $5.06 | $43K | 75,532 |
| 2026-02-17 | de los Pinos Elisabet See Remarks | Sale | −47,648 | $5.06 | $241K | 409,815 |
| 2026-01-20 | Elazzouzi Amy Senior Vice President, Finance | Sale | −1,581 | $4.86 | $8K | 84,081 |
| 2026-01-20 | de los Pinos Elisabet See Remarks | Sale | −16,928 | $4.86 | $82K | 457,463 |
| 2025-11-17 | Hopkins Janet Jill Chief Medical Officer | Sale | −17,109 | $5.42 | $93K | 252,685 |
| 2025-10-29 | Elazzouzi Amy Senior Vice President, Finance | Sale | −896 | $6.35 | $6K | 85,662 |
| 2025-10-29 | de los Pinos Elisabet See Remarks | Sale | −9,049 | $6.35 | $57K | 474,391 |
| 2025-10-16 | Plavsic Mark Chief Technology Officer | Sale | −12,169 | $6.35 | $77K | 197,287 |
| 2025-08-18 | Elazzouzi Amy Senior Vice President, Finance | Option exercise | +2,554 | $5.07 | $13K | 83,935 |
| 2025-08-18 | Elazzouzi Amy Senior Vice President, Finance | Option exercise | +1,094 | $5.48 | $6K | 85,029 |
| 2025-08-18 | Elazzouzi Amy Senior Vice President, Finance | Option exercise | +547 | $5.48 | $3K | 85,576 |
| 2025-08-18 | Elazzouzi Amy Senior Vice President, Finance | Option exercise | +547 | $5.21 | $3K | 86,123 |
| 2025-08-18 | Elazzouzi Amy Senior Vice President, Finance | Option exercise | +4,744 | $2.74 | $13K | 90,867 |
| 2025-08-18 | Elazzouzi Amy Senior Vice President, Finance | Option exercise | +1,094 | $3.16 | $3K | 91,961 |
| 2025-08-18 | Elazzouzi Amy Senior Vice President, Finance | Option exercise | +2,319 | $4.25 | $10K | 94,280 |
| 2025-08-18 | Elazzouzi Amy Senior Vice President, Finance | Sale | −7,722 | $6.70 | $52K | 86,558 |
| 2025-08-18 | Elazzouzi Amy Senior Vice President, Finance | Option exercise · Stock Option (Right to Buy) | −2,554 | 0 | ||
| 2025-08-18 | Elazzouzi Amy Senior Vice President, Finance | Option exercise · Stock Option (Right to Buy) | −1,094 | 0 |
Page 3 of 11 · 219 trades